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The Helicobacter pylori type IV secretion effector
CagA is a major bacterial virulence determinant and
critical for gastric carcinogenesis. Upon delivery
into gastric epithelial cells, CagA localizes to the
inner face of the plasma membrane, where it acts
as a pathogenic scaffold/hub that promiscuously
recruits host proteins to potentiate oncogenic
signaling. We find that CagA comprises a structured
N-terminal region and an intrinsically disordered
C-terminal region that directs versatile protein
interactions. X-ray crystallographic analysis of the
N-terminal CagA fragment (residues 1-876) revealed
that the region has a structure comprised of three
discrete domains. Domain I constitutes a mobile
CagA N terminus, while Domain II tethers CagA
to the plasma membrane by interacting with mem-
brane phosphatidylserine. Domain III interacts
intramolecularly with the intrinsically disordered
C-terminal region, and this interaction potentiates
the pathogenic scaffold/hub function of CagA.
The present work provides a tertiary-structural
basis for the pathophysiological/oncogenic action
of H. pylori CagA.
INTRODUCTION
Chronic infection with Helicobacter pylori cagA-positive strains
is associated with atrophic gastritis and peptic ulcerations and
is the strongest risk factor for the development of gastric carci-
noma, the second leading cause of cancer-related death world-20 Cell Host & Microbe 12, 20–33, July 19, 2012 ª2012 Elsevier Inc.wide (Blaser and Atherton, 2004; Parsonnet et al., 1997). The
cagA-encoded CagA is a 120145 kDa protein, which is
delivered into gastric epithelial cells via a type IV secretion
system (TFSS) (Covacci and Rappuoli, 2000). The CagA delivery
requires binding of bacterial surface-exposed CagA, particularly
at the TFSS pilus tip (Jime´nez-Soto et al., 2009; Kwok et al.,
2007), with phosphatidylserine (PS), which is normally concen-
trated to the inner leaflet of the plasma membrane in host cells
but is transiently externalized to the membrane surface where
H. pylori directly attached (Murata-Kamiya et al., 2010). Interac-
tion of integrin b1 with CagA as well as TFSS components such
as CagI, CagL and CagY is also involved in the translocalization
of CagA (Jime´nez-Soto et al., 2009; Kwok et al., 2007). The
CagA protein is noted for sequence diversity in its C-terminal
region that contains a variable number of Glu-Pro-Ile-Tyr-Ala
(EPIYA) tyrosine-phosphorylation motifs, and, based on charac-
teristics of the amino acids flanking each of the EPIYA motifs,
four distinct EPIYA segments (A-D) have been identified (Higa-
shi et al., 2002a; Xia et al., 2009). The C-terminal region of
CagA from East Asian H. pylori strains (East Asian CagA)
contains EPIYA-A and EPIYA-B segments, which are followed
by one EPIYA-D segment, whereas that of H. pylori isolated
from the rest of the world (Western CagA) contains EPIYA-A
and EPIYA-B segments, followed by one to three repeats of
EPIYA-C segment. Accordingly, variations in molecular size of
CagA are mostly due to differential combinations of EPIYA
segments.
Once inside the host cell, CagA is tethered to the inner face of
the plasma membrane, where it exerts its pathophysiological
action (Higashi et al., 2002b; Bagnoli et al., 2005). In nonpolar-
ized epithelial cells, the EPIYA segment acts as a membrane-
localization signal of CagA (Higashi et al., 2005). In contrast,
in polarized epithelial cells, interaction of CagA with PS, which
is abundantly present in the inner leaflet of the plasma
membrane, plays an important role in the membrane association
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2010). Membrane-tethered CagA then undergoes tyrosine
phosphorylation at the EPIYA motifs by Src family kinases
(SFKs) or c-Abl kinase (Backert and Meyer, 2006) and thereby
acquires the ability to promiscuously interact with SH2-domain
containing proteins such as SHP2 tyrosine phosphatase,
C-terminal Src kinase (Csk), and Crk adaptor (Hatakeyama,
2004; Higashi et al., 2002b; Suzuki et al., 2005). Among these,
SHP2 is known as a bona fide oncoprotein, gain-of-function
mutations of which are associated with a variety of humanmalig-
nancies (Mohi and Neel, 2007). Through complex formation,
CagA also deregulates SHP2 phosphatase activity, causing
aberrant activation of pro-oncogenic Erk MAP kinase signaling
(Hatakeyama, 2004). Additionally, CagA binds to the polarity-
regulating serine/threonine kinase Partitioning defective-1
(PAR1)/Microtubule affinity-regulating kinase (MARK) (Lu et al.,
2009; Saadat et al., 2007; Zeaiter et al., 2008). The CagA-PAR1
interaction occurs between the 16 amino-acid residues termed
the CM (CagA multimerization) or MKI (MARK-kinase inhibitor)
sequence in C-terminal CagA and the kinase catalytic domain
of PAR1 (Nesic et al., 2010; Ren et al., 2006; Saadat et al.,
2007). Through this interaction, CagA inhibits PAR1 kinase
activity and thereby causes junctional and polarity defects,
which also contribute to epithelial cell transformation (Saadat
et al., 2007). Conversely, PAR1, which forms a homodimer
(Nagase et al., 2011), tethers two CagA proteins at the CM
sequences and this CagA tethering potentiates CagA-SHP2
complex formation and subsequent deregulation of SHP2 (Lu
et al., 2008, 2009; Saadat et al., 2007). Consequently, CagA-
mediated signal perturbation triggers a morphogenetic change
in gastric epithelial cells characterized by an extremely elon-
gated cell shape known as the ‘‘hummingbird phenotype’’ (Segal
et al., 1999). In vivo oncogenic potential of CagA has been
demonstrated by the observation that transgenic CagA expres-
sion spontaneously induces gastrointestinal and hematological
malignancies in mice (Ohnishi et al., 2008).
Elucidation of the three-dimensional structure of CagA is
a major challenge that has so far been hampered by the large
size, lack of homology, and high protease susceptibility of
CagA (Angelini et al., 2009; Hohlfeld et al., 2006). In this work,
we determined the tertiary structure of CagA, and we discuss it
here in terms of CagA functions.
RESULTS
Biological and Physicochemical Properties of
Recombinant H. pylori CagA Protein
The recombinant full-length CagA protein (a 135-kD Western
CagA of 1186 amino-acid residues derived from H. pylori
strain 26695) expressed in Escherichia coli as a GST fusion
protein was purified using glutathione beads and was then
cleaved with PreScission protease. Since CagA does not
share sequence homology with any of the known proteins,
we first wished to obtain structural information on CagA by
limited proteolysis. Upon partial digestion with Staphylococcus
aureus V8 protease, full-length CagA was cleaved into 100-kD
and 35-kD fragments (Figure S1A). The V8 protease digestion
pattern was reproducible with another CagA of H. pylori
NCTC11637 strain origin (Figure S1B). Amino-acid sequencingCrevealed that the N terminus of the 100-kD fragment was iden-
tical to that of full-length CagA, whereas the 35-kD fragment
started from residue 877 (L877) of CagA (Figure S1A). An
immunoblotting experiment showed that the 35-kD fragment
contained a hexahistidine (6xHis)-tag fused to the C terminus
of recombinant CagA (Figure S1C). From these results, we de-
noted the N-terminal 100-kD fragment (residues 1-876) and the
C-terminal 35-kD fragment (residues 877-1186) as CagA(1-876)
and CagA(877-1186), respectively (Figure 1A). Cleavage of
CagA into 100-kD and 35-kD fragments had been previously
reported to occur (Jime´nez-Soto et al., 2009; Moese et al.,
2001), although the actual protease and pathobiological signif-
icance of this CagA processing is still not known. We also
performed a limited proteolysis of recombinant CagA(1-876)
with trypsin and obtained two major fragments, one corre-
sponding to residues 1-260, CagA(1-260), and the other corre-
sponding to residues 261-829, CagA(261-829) (Figures 1A,
S1D, and S1E).
The C-terminal CagA(877-1186) contains the EPIYA segment
and CM sequence, which respectively act as binding sites for
SHP2 and PAR1 (Higashi et al., 2002b; Saadat et al., 2007).
The scaffold/hub function of C-terminal CagA is responsible
for the morphogenetic activity of CagA known as the humming-
bird phenotype (Bagnoli et al., 2005; Higashi et al., 2005). To
determine whether the recombinant CagA(877-1186) purified
from E. coli was biologically active, we utilized CagA-PAR1
interaction as an experimental read-out that quantitatively eval-
uates the scaffold/hub function of C-terminal CagA. To do so,
CagA(877-1186), either produced in E. coli or expressed in
COS-7 cells, was mixed with lysates of COS-7 cells expressing
FLAG-tagged PAR1b, a major PAR1 isoform in epithelial cells,
and complex formation of CagA with PAR1b was examined by
co-immunoprecipitation (Lu et al., 2008). The in vitro mixing
experiment demonstrated that E. coli-derived CagA(877-1186)
bound to PAR1b to a level comparable to that observed with
COS-7-derived CagA(877-1186) (Figure 1B). We then tested
the morphogenetic activity of recombinant CagA proteins
purified from E. coli in AGS human gastric epithelial cells by
microinjection and confirmed the hummingbird-inducing activity
of CagA(877-1186), although the magnitude was less than
that induced by full-length CagA (Figure 1C and Movies
S1–S3). Thus, recombinant CagA(877-1186) had an attenuated
but substantial level of CagA activity.
To investigate the physicochemical property of the biologically
active C-terminal CagA, we performed 1H-NMR analysis of re-
combinant CagA(877-1186). The 1H-NMR spectrum showed
weak dispersion and crowded peaks of amide proton chemical
shifts around the 8-ppm region (Figure 1D). Spectrum data
with similar characteristics were also obtained with recombinant
CagA(873-1026), which corresponded to the EPIYA segments
(EPIYA-A, -B and -C), purified from E. coli (Figure S1F). The
results of the NMR study indicated that the CagA C-terminal
fragment (residues 877-1186) is virtually free from a high-order
structure. Since EPIYA segments of C-terminal CagA had been
predicted to be disordered (Angelini et al., 2009; Nesic et al.,
2010), our result extended results of previous studies by demon-
strating that the CagA C-terminal region up to the very
C terminus is intrinsically disordered and therefore lacks a solid
structure.ell Host & Microbe 12, 20–33, July 19, 2012 ª2012 Elsevier Inc. 21
Figure 1. Structure and Activity of CagA Proteolytic Fragments
(A) Schematic representation of the partial digestion patterns of full-length CagA and CagA(1-876) by S. aureus V8 protease and trypsin.
(B) CagA(877-1186) produced in COS-7 cells or in E. coli was mixed with FLAG-tagged PAR1b expressed in COS-7 cells and the complex formation was
determined by co-immunoprecipitation.
(C) Recombinant full-length CagA, CagA(1-876) or CagA(877-1186) purified from E. coliwasmicroinjected into AGS cells and cell shapes were observed. All cells
in the pictures were microinjected with CagA. Arrowheads indicate elongated cells.
(D) 1H NMR spectrum of recombinant CagA(877-1186). See also Figure S1.
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CagA binds to PAR1 via the C-terminal CM sequence (Lu et al.,
2008; Nesic et al., 2010; Saadat et al., 2007). Using surface plas-
mon resonance (SPR) spectroscopy, we directly measured
binding affinity of recombinant CagA to PAR1 (Figure 2A). Full-
length CagA bound to PAR1b (residues 39-364) with a KD value
of 3.9 ± 0.64 nM. In contrast, C-terminal CagA(877-1186) bound
to PAR1b (KD = 33.0 ± 9.3 nM) with a strength that was one order
of magnitude less than that of full-length CagA. Since N-terminal22 Cell Host & Microbe 12, 20–33, July 19, 2012 ª2012 Elsevier Inc.CagA(1-876) did not directly bind to PAR1, the result suggested
the presence of a functional interplay between the N-terminal
region and C-terminal region that strengthens binding of
C-terminal CagA to PAR1. In this regard, Bagnoli et al. had
reported that N-terminal CagA associates with C-terminal
CagA and that this intramolecular interaction potentiates the
morphogenetic activity of C-terminal CagA (Bagnoli et al.,
2005). We therefore wished to elucidate the mechanistic details
of the N-terminal/C-terminal interaction. To do so, we first nar-
rowed down CagA sequences that mediate the intramolecular
Figure 2. Intramolecular Interaction of CagA
(A) Binding affinities of recombinant CagA proteins to immobilized recombinant PAR1b (residues 39-364) were determined by SPR spectroscopy.
(B and C) Each of the FLAG-tagged CagA(1-876) mutants expressed in COS-7 cells was in vitro mixed with recombinant CagA(877-1186) and the complex
formation was determined by co-immunoprecipitation.
(D) Interaction of recombinant CagA(877-1186) with FLAG-tagged CagA(1-876) expressed in COS-7 cells was examined by co-immunoprecipitation in the
presence of the indicated peptide derived from C-terminal CagA.
(E) FLAG-tagged CagA(1-876) expressed in COS-7 cells was in vitro mixed with CagA(877-1186) or CagA(877-1186jD998-1038), in which residues 998-1038
were deleted from CagA(877-1186). The N-terminal/C-terminal interaction of CagA was then investigated by a co-immunoprecipitation experiment.
(F) Schematic view of CagA regions responsible for the intramolecular N-terminal/C-terminal intramolecular interaction.
(G) Amino-acid sequence homology between NBS and CBS.
(H) SHP2-binding activities of full-length CagA and CagAD998-1038 (left). AGS cells were transfected with the indicated CagA expression vectors (second left).
The number of hummingbird cells was counted (second right). Relative cell length was also quantified (right). Error bars represent mean ± S.D., *p < 0.05
(Student’s t test, n = 3), ***p < 0.00001 (Mann-Whitney U test, n = 100). See also Figure S2.
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Table 1. Crystallographic Summary
MAD data (CagA(261–829)) CagA(261–829) CagA(1–876)
Data Collection
Space group P3121 P41212
Cell dimensions
a, b, c (A˚) 96.41, 96.41, 171.59 95.67, 95.67, 167.92 97.31, 97.31 244.76
a, b, g () 90, 90, 120 90, 90, 120 90, 90, 90
Peak Inflection
Wavelength (A˚) 0.9806 0.9809 0.9806 0.9790
Resolution (A˚) 83.5 – 3.30 (3.47 – 3.30) 83.6 – 3.35 (3.53 – 3.35) 74.3 – 3.19 (3.37 – 3.19) 90.42 – 3.30 (3.58 – 3.30)
Rmerge 0.038 (0.420) 0.037 (0.427) 0.059 (0.468) 0.054 (0.5050)
I/sI 30.70 (4.66) 32.51 (4.58) 33.39 (6.00) 25.23 (4.42)
Completeness (%) 99.2 (100) 99.4 (100) 99.3 (100) 99.5 (100)
Redundancy 5.7 (5.7) 5.7 (5.8) 10.6 (11.1) 7.6 (7.7)
Crystallographic Refinement
Resolution (A˚) 74.3 – 3.19 (3.41 – 3.19) 90.42 – 3.30 (3.50 – 3.30)
No. of reflections 15,242 18,403
Rwork/Rfree 0.2215/0.2786 (0.2478/0.3041) 0.1905/0.2476 (0.2241/0.2820)
No of atoms
Protein 3635 5229
Ligand/Ion - -
Water - -
B-factors (A˚2)
Protein 103.74 145.89
Ligand/Ion -
Water -
Rms deviations
Bond lengths (A˚) 0.010 0.010
Bond angles () 1.21 1.22
Each data set was collected from one crystal. Highest resolution shell is shown in parentheses.
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cells expressing a series of CagA(1-876) mutants with recombi-
nant CagA(877-1186). The results of a co-immunoprecipitation
experiment revealed that deletion of residues 554-617 or 708-
821 abolished the ability of N-terminal CagA to bind C-terminal
CagA (Figures 2B and 2C). In addition, results of a binding-
competition experiment using a series of peptides derived
fromC-terminal CagA and a co-immunoprecipitation experiment
using internal deletion mutants of CagA(877-1186) indicated
that residues 998-1038 are responsible for interaction with
N-terminal CagA (Figures 2D–2F). To our surprise, the identified
C-terminal binding residues 998-1038 exhibited significant
sequence homology (54% identity) with the N-terminal residues
782-820, which were within the N-terminal CagA sequence
required for C-terminal CagA binding (Figure 2G). The homology
was more evident when nucleotide sequences were compared
(70% identity) (Figure S2), suggesting that these two CagA
sequences have been derived from the same ancestral DNA
fragment through duplication. We termed residues 782-820 as
N-terminal binding sequence (NBS) and residues 998-1038
as C-terminal binding sequence (CBS) (Figure 2F). Whereas
CBS contained neither an EPIYA motif nor CM sequence, a
CagA mutant lacking CBS (CagAD998-1038) had substantially24 Cell Host & Microbe 12, 20–33, July 19, 2012 ª2012 Elsevier Inc.reduced SHP2-binding activity and decreased hummingbird-
inducing activity in AGS cells (Figure 2H), providing additional
evidence for the importance of intramolecular CagA interac-
tion in enhancing the pathophysiological activity of C-terminal
CagA. Given that CagA-PAR1 interaction is important for stable
CagA-SHP2 complex formation (Saadat et al., 2007), the atten-
uated CagA activity was most probably due to weakened
CagA-PAR1 interaction in the absence of N-terminal/C-terminal
interaction of CagA.
Crystal Structure of the CagA N-Terminal Region
Next, we sought to crystallize the CagA protein. Whereas re-
combinant CagA(1-876) and CagA(261-829) were successfully
crystallized, full-length CagA crystal was never obtained, sug-
gesting that the disordered C-terminal CagA hampered crystal-
lization of full-length CagA. X-ray analysis initially solved the
crystal structure of CagA(261-829) at 3.19 A˚ resolution by the
multiwavelength anomalous dispersion (MAD) method (Table 1
and Figure 3A). To validate sequence assignment of the crystal
structure, we prepared 31 mutant derivatives, each of which
contains different selenomethionine (SeMet) substitutions (Table
S1 and Figure S3A). Using the CagA(261-829) crystal structure
as a search model, the crystal structure of CagA(1-876) was
Figure 3. Crystal Structure of the CagA N-Terminal Region
(A and B) Cartoon diagram (upper) and surface representation (lower) of the crystal structures of CagA(261-829) (A) and CagA(1-876) (B).
(C) B-factor representation of CagA(261-829) (left) and CagA(1-876) (right) from blue (low) to red (high).
(D) Domains II and III in CagA(261-829) (pink) and CagA(1-876) (cyan) were superimposed by least-squares fitting.
(E) Summary of structural comparison between CagA(1-876) and CagA(261-829). See also Figure S3.
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(Table 1 and Figure 3B). Since the electron density of CagA(1-
876) was poor, 10 mutants of CagA(1-876) were utilized for
amino acid assignment (Table S1 and Figure S3A). The electron
density map obtained from the CagA(1-876) crystal resolved the
N terminus end region of CagA (residues 24-221), which corre-
sponded to the smaller fragment of the trypsin-digested CagA
N-terminal region (Figure 1A). On the other hand, no electron
densities were observed for residues 825-876, suggesting that
these residues were structurally disordered. We thus concludedCthat the entire CagA protein comprises a structured N-terminal
region (residues 1-829) (Table S2) and an intrinsically disordered
C-terminal region (830-1186).
The crystal structure of the CagA N-terminal region (residues
1-829) assumed a square plate-like shape with approximate
dimensions of 110 3 80 3 55 A˚3 (Figures 3B and 4). Whereas
the overall structure was defined, N-terminal CagA was charac-
terized by the existence of short disordered stretches such as
residues 222-302, 479-488, and 510-536, of which electron
densities were not observed in any crystal form (Figure 4 andell Host & Microbe 12, 20–33, July 19, 2012 ª2012 Elsevier Inc. 25
Figure 4. Domain definition and sequence alignment with secondary structure elements of CagA
(A) Topological configurations of the secondary structures of CagA(1-876).
(B) The secondary structure was assigned to CagA sequence based on the crystal structure of CagA(1-876). See also Figure S4.
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Domains I-III. Domain I, the most N-terminal domain, was
made up of 10 a helices (a1–a10) and was structurally isolated26 Cell Host & Microbe 12, 20–33, July 19, 2012 ª2012 Elsevier Inc.from the other two domains; Domain I has a small interacting
surface area (374 A˚2) with Domain II but has no interaction with
Domain III. Because of this weak interaction with other parts of
Cell Host & Microbe
Tertiary Structural Basis for CagA Actionthemolecule, Domain I is likely to have amobile character, which
was supported by high B-factors of residues in Domain I (Fig-
ure 3C). Domain II and Domain III, which corresponded to resi-
dues 303-644 and 645-824 (Figure 4), respectively, comprised
a protease-resistant CagA structural core that showed an
N-shaped dimodular architecture. Domains II and III were con-
nected by a long helix a19, which is kinked at around residue
670 by approximately 30. Domain II contained a large anti-
parallel b sheet, which had an insertion of a subdomain (residues
370-446) between b5 and b8 strands. This subdomain, located at
the center of the N-terminal region of CagA, tightly interacted
with the inner surface of the b sheet. Two a helices, a17 and
a18, also interacted with the inner surface of the b sheet.
B-factor values of the residues in the large b sheet and the sub-
domain were lower than those of residues in other regions (Fig-
ure 3C), suggesting that these structural elements comprise
a rigid core of CagA. Indeed, this region showed a small struc-
tural deviation between CagA(1-876) and CagA(261-829); the
root-mean-square structural displacement was 0.64 A˚ for 183
CA atoms (Figures 3D and 3E). On the other hand, the long
a19 helix that connects Domain II and Domain III seemed to be
flexible (Figure S3C). The bent angle of the a19 helix was signif-
icantly different between CagA(1-876) and CagA(261-829), re-
sulting in a change of relative disposition of Domain III between
CagA(1-876) and CagA(261-829) (Figure 3D). In Domain III,
helices a20, a21, and a22 formed a 4-helix bundle with the
C-terminal region of the a19 helix (Figures 3A, 3B, and 4). Resi-
dues 554-617 and residues 708-821, deletion of which abolished
the intramolecular CagA interaction, constituted helices a16-a18
in Domain II and helices a20-a23 in Domain III, respectively. Also,
NBS (residues 782-820), which associates with CBS (residues
998-1038) in C-terminal CagA, formed a part of helices a22/23
(Figure 4B). A structural homology search using the DALI server
(Holm and Sander, 1996) revealed that the tertiary structure of
the N-terminal CagA region was unprecedented, with no homol-
ogous structure reported (Figure S4).
Basic Amino-Acid Cluster in Domain II
CagA binds to the acidic membrane phospholipid, PS (Murata-
Kamiya et al., 2010). Whereas PS is physiologically concentrated
to the inner leaflet of the plasma membrane, it is transiently
externalized to the outer leaflet at the membrane site where
H. pylori directly attached. Interaction of CagA with PS is impor-
tant not only for the delivery of CagA into host cells but also for
the localization of delivered CagA to the inner face of the plasma
membrane, especially in polarized epithelial cells (Murata-Ka-
miya et al., 2010). Two arginine residues, R624 and R626
(R619 and R621 in NCTC11637-derived CagA), both of which
are crucial for the CagA-PS interaction, were located in helix
a18 of Domain II (Figure 5A). The crystal structure of N-terminal
CagA revealed that, together with R624 and R626, lysine resi-
dues at 454, 455, 458, 476, 613, 614, 617, 621, 625, 631, 635,
636, 646, and 650 constitute a basic amino-acid cluster that
provides a positive electrostatic surface potential (Figure 5A).
Given this, we hypothesized that the basic patch mediates the
CagA-PS interaction. A series of basic patch mutants of CagA
were then prepared and subjected to an in vitro lipid-binding
assay or transient expression in polarized Madin-Darby canine
kidney (MDCK) cells. The results of the experiments revealedCinvolvement of K613, K614, K617, K621, K631, K635 and
K636, in addition to R624 and R626, in the CagA-PS interaction
(Figures 5B and 5C), confirming that the basic patch acts like
Velcro to mediate the CagA-PS interaction. From this observa-
tion, we also assumed that the basic patch faces the inner side
of the plasma membrane, where PS is present, and deduced
molecular orientation of delivered CagA relative to the plasma
membrane as described in Figure 5D.
Functional Studies of the Structured CagA N-Terminal
Region
Packing analysis of the P41212 and P3121 crystals showed that
similar intermolecular interactions that dimerize N-terminal
CagA occurred in both crystal forms (Figures 6A and S5A). The
two molecules in the dimer were related to each other by a crys-
tallographic two-fold axis in both crystal forms; helices a22 and
a23 of two adjacent N-terminal CagA fragments underwent
hydrophobic interactions by forming an intermolecular 4-helix
bundle in these dimers. In the P41212 crystal, the dimerization
interface comprised nine hydrophobic residues, centering
around L792 in helix a22 and L812 in helix a23. (Figure 6A).
The interaction buried 627 A˚2 of the surface per partner mole-
cule. Substitution of L792 or L812 with SeMet caused significant
loss of integrity of the mutant crystal (Table S1). The N-terminal
dimerization and the formation of intermolecular 4-helix bundle
were also preserved in the CagA(261-829) crystal with the
P3121 space group (Figure S5A), although relative arrangement
of the two molecules was slightly different from that observed
in the P41212 crystal. These observations indicated the impor-
tance of intermolecular contacts for the quality of CagA crystals.
They also raised the idea that N-terminal CagA spontaneously
dimerizes independently of C-terminal CagA. However, the
results of static light scattering analysis demonstrated that full-
length CagA or the CagA(1-876) fragment purified from E. coli
was present as a monomer in solutions up to the concentration
of 6 mM (Figure 6B). In this regard, the first peak of full-length
CagA in the gel filtration profile corresponded to a CagA dimer.
However, the peak was markedly decreased in the presence of
dithiothreitol (Figure S5B). Also, such dimer peak was absent
when the N-terminal CagA(1-876) fragment was applied (Fig-
ure 6B). These results indicated that the dimer peak was artifi-
cially made by an intermolecular disulfide bond at C1164, the
only cysteine residue present in C-terminal CagA (residues
877-1186). Furthermore, a GST pull-down experiment using
a solution containing 72 mM GST-CagA(1-876) and 310 mM
FLAG-CagA(1-876) provided no evidence for the spontaneous
dimerization of N-terminal CagA (data not shown). Together
with the small interaction surface of the dimer (627 A2) in
the crystal, these results favored the idea that the N-terminal
CagA dimerization was due to crystal packing. Although the bio-
logical relevance of the N-terminal CagA dimerization remains
unknown, we noticed that the sequence that forms the dimer
interface in the crystal overlaps with NBS (residues 782-820)
(Figure 2F). Furthermore, nine hydrophobic residues in NBS
that constitute the hydrophobic interaction surface in the crys-
tal were completely conserved in the NBS-related CBS (Fig-
ure 4B). This unexpected finding led us to examine whether the
N-terminal dimerization interface in the crystal was also utilized
for the intramolecular N-terminal/C-terminal interaction. To thisell Host & Microbe 12, 20–33, July 19, 2012 ª2012 Elsevier Inc. 27
Figure 5. Involvement of Basic Patch in the Membrane Association of CagA
(A) Clustered amino-acid residues that comprise the basic patch on the Domain II of N-terminal CagA are highlighted in different colors.
(B) Phospholipid-binding assay of recombinant CagA proteins having variable combinations of mutations in the basic patch.
(C) Polarized MDCK cells were transfected with the indicated CagA vector, and subcellular localization of CagA was investigated by immunofluorescence
microscopy.
(D) A model of CagA-host membrane interaction.
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which one or both of L792 and L812 were replaced by arginine.
GST pull-down experiments using a mixture of the GST-fusion
protein and C-terminal CagA(877-1186) revealed that the
N-terminal/C-terminal interaction was completely abolished by
L792R or L812Rmutation in NBS (Figure 6C), indicating a critical
role for the hydrophobic NBS/CBS interaction in the N-terminal/
C-terminal association of CagA. In this regard, N-terminal dele-
tion to residue 617 also abolished the N-terminal/C-terminal
interaction (Figures 2C and 2F). Whereas the deletion does not
involve NBS, deletion of most part of Domain I and Doman II
seems to affect Domain III, which most likely disintegrates the
CagA structure required for the NBS-CBS interaction.
Since CBS was located immediately distal to the PAR1-
binding CM sequence in C-terminal CagA (Figure 4B), it was28 Cell Host & Microbe 12, 20–33, July 19, 2012 ª2012 Elsevier Inc.possible that the intramolecular NBS/CBS interaction influences
the binding of PAR1 to the CM sequence. By surface plasmon
resonance analysis, the equilibrium dissociation constants
(KD) obtained for binding of PAR1 to wild-type CagA and
CagA(L812R) were almost the same. However, the kinetics of
PAR1 binding to CagA(L812R) were substantially different from
those obtained using wild-type CagA: PAR1 associated with
and dissociated from CagA(L812R) more rapidly than to wild-
type CagA (Figure 6D, lower). The results indicated that turnover
of the CagA-PAR1 complex was accelerated in the absence of
the intramolecular NBS/CBS interaction of CagA. Since PAR1-
mediated tethering of two CagA proteins via the CM sequence
markedly stimulates CagA-SHP2 complex formation (Saadat
et al., 2007), elevated turnover of the CagA-PAR1 complex
was thought to influence the CagA-SHP2 interaction. Indeed,
Figure 6. Role of the N-Terminal Dimerization Surface in the N-Terminal/C-Terminal CagA Interaction
(A) A CagA(1-876) dimer in the crystal. An intermolecular 4-helix bundle is formed between two adjacent CagA(1-876) monomers.
(B) Molecular weights of CagA in solution were determined by measuring intensity of static light scattering (LS) and refractive index (RI).
(C) CagA(877-1186) mixed with GST-fused full-length CagA or CagA(1-876) was subjected to a GST pull-down assay.
(D) Binding kinetics between PAR1b and CagA mutant that cannot undergo intramolecular NBS/CBS interaction. Error bars represent mean ± S.D., *p < 0.001
(Student’s t test, n = 3).
(E) Lysates of AGS cells transfected with the indicated FLAG-CagA vector were immunoprecipitated (IP) with an anti-FLAG antibody, followed by immunoblotting
(IB) with the respective antibodies.
(F) Induction of hummingbird cells in AGS cells by CagA (upper) was statistically analyzed (lower). Error bars represent mean ± S.D., **p < 0.01 (Student’s t test,
n = 3), ***p < 0.00001 (Mann-Whitney U test, n = 100).
(G) Gel filtration profiles of recombinant CagA proteins.
(H) Prediction of secondary structure contents for recombinant CagA proteins purified from E. coli by CD spectra. See also Figure S5.
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Tertiary Structural Basis for CagA ActionCagA mutants that did not undergo NBS/CBS interaction ex-
hibited reduced complex formation with SHP2 and showed
decreased hummingbird-inducing ability in AGS cells (Figures
6E, 6F, S5C, and S5D). Next, to gain insights into the mechanism
that affects the stability of the CagA-PAR1 complex, we investi-
gated structural alterations in the disordered C-terminal region
following the NBS/CBS interaction. Notably, the intramolecular
interaction creates a lariat-like C-terminal loop (Figure S5E) while
making the entire CagA structure more compact (Figure 6G). By
circular dichroism (CD) spectrum analysis of E. coli-purified re-
combinant proteins, the N-terminal CagA(1-876) fragment gave
particular CD peaks at 208 nm and 222 nm derived from
a helices, and the helix content was estimated from CD
spectra data to be approximately 58%, whereas the C-terminal
CagA(877-1186) was virtually free of a secondary structure
(Figure 6H). To our surprise, the CD spectra of full-length CagA
were similar to those of CagA(1-876) despite the presence of
the disordered C-terminal CagA region. The helix content of
full-length CagA was, however, reduced to 41% upon introduc-
tion of the L812R mutation that disabled the NBS/CBS interac-
tion (Figure 6H). Since a stronger L792/812R mutation did not
alter the helix content of the CagA(1-876) fragment (Figure 6H),
the possibility that the L812R mutation perturbed the overall
structure of the folded N-terminal CagA was excluded. These
results collectively indicated that, upon NBS/CBS interaction,
a substantial portion of the intrinsically disordered C-terminal
CagA adopted a secondary structure known as ‘‘induced fold-
ing’’ or ‘‘disorder-to-order transition,’’ which plays an important
role in the interaction of intrinsically disordered protein/region
with target protein (Dunker et al., 2008; Dyson and Wright,
2005; Fink, 2005; Sigalov, 2010). Adaptive folding induced within
or near the CM sequence in the C-terminal loop may therefore
underlie reduced turnover of the CagA-PAR1 complex in
response to the intramolecular NBS/CBS interaction, which
potentiates the pathogenic scaffold/hub function of CagA.
DISCUSSION
In the present study, we elucidated the tertiary structure of the
H. pylori CagA protein, the only known bacterial oncoprotein
playing a critical role in human gastric carcinogenesis. CagA
consists of a structured N-terminal region (70% of the entire
protein) and an intrinsically disordered C-terminal region
(30% of the entire protein). The crystal analysis revealed that
the structured N-terminal CagA comprises three domains,
Domains I-III. Domain I, which comprises the CagA N-terminal
end, is linked to Domain II by a disordered region with about
80 amino acids. Since interaction surface is very small
(385 A˚2), Domain I could be easily dissociated from Domain II
and thus could be highly mobile in solution. Domain II and
Domain III, bridged by a single long a-helix, form a unique
‘‘N-shaped’’ structural core of CagA made from 13 a helices
and a huge b sheet. Interestingly, the structured N-terminal
CagA still contains short disordered regions such as residues
222-302, 479-488, and 510-536. Since these disordered regions
are common in all crystal forms, their presence may be a unique
structural property of N-terminal CagA. Such disordered regions
would not only act as flexible linkers between structured
portions/domains but also serve as sites for molecular interac-30 Cell Host & Microbe 12, 20–33, July 19, 2012 ª2012 Elsevier Inc.tion, modification and so on. Indeed, N-terminal residues
204-236, which form a short helix and a disordered segment,
have been reported to interact with RUNX3, a gastric tumor
suppressor (Tsang et al., 2010). Residues 120-152 located on
the same side of Domain I then promote degradation of CagA-
bound RUNX3 by recruiting E3 ubiquitin ligase. This RUNX3
degradation was presumed to be mediated via WW domains in
these CagA sequences. Our structural data, however, argue
against the presence of such domains in N-terminal CagA.
In the crystal, N-terminal CagA dimerizes by hydrophobic
interaction, in which L792 in helix a22 and L812 in helix a23
act as critical residues. Whereas the observed N-terminal
CagA dimerization could be due to crystal packing, these two
leucine residues within NBS were also indispensable for the
intramolecular interaction of N-terminal CagA with C-terminal
CagA, which appears to be mediated through the hydrophobic
interaction between NBS and CBS (Figure S5E). Intriguingly,
CBS exhibits substantial homology with NBS, most probably
because these two sequences have been derived from an
ancestral genomic segment. Despite the sequence similarity,
however, NBS is folded into helices, while CBS is intrinsically
disordered. We suspect that, upon interaction with NBS, CBS
undergoes an induced folding that resembles the NBS helices.
Extending this idea, the intermolecular NBS-NBS interaction in
N-terminal CagA crystal, mediated by 4-helix bundle formation,
might reflect the intramolecular interaction between NBS and
NBS-related CBS in full-length CagA (Figure S5E). This idea
was supported by 4-helix bundle formation between NBS and
CBS through molecular modeling study (Figure S5F).
H. pylori injects CagA into the attached cells via TFSS.
Although it remains unknown if CagA is delivered through the
TFSS channel, the calculated size of the structured N-terminal
CagA (110 3 80 3 55 A˚3) is smaller than the estimated diameter
for the conduit of the H. pylori TFSS pilus (120 A˚) (Rohde et al.,
2003). Upon delivery, CagA is tethered to the inner face of the
plasma membrane by interacting with PS, which is selectively
enriched in the inner leaflet (Murata-Kamiya et al., 2010).
A cluster of basic residues (basic patch) present on the surface
of Domain II acts like Velcro to direct the CagA-PS interaction
(Figure S5G). Involvement of multiple lysine and arginine resi-
dues in the CagA-PS interaction suggests the role of a poly-
electrostatic effect in which the net charge of the basic patch
influences the strength of CagA binding to PS. The CagA
N-terminal residues 1-200 have recently been reported to act
as yet another membrane-binding site, which targets CagA to
the different membrane compartments and thereby regulates
CagA functions (Pelz et al., 2011).
CagA exerts its oncogenic action by promiscuously interacting
with multiple host proteins (Hatakeyama, 2008; Selbach et al.,
2009). The intrinsically disordered nature of C-terminal CagA
enables versatile CagA interaction because of its structural flex-
ibility (Dunker et al., 2008; Dyson and Wright, 2005; Fink, 2005;
Sigalov, 2010). This promiscuous CagA interaction is in many
cases mediated via the EPIYA segment or CM sequence in the
disordered C-terminal CagA (Hatakeyama, 2008). The EPIYA
segments bind to SH2 domain-containing proteins such as
SHP2, Csk, Grb2 and Crk (Hatakeyama, 2004; Mimuro et al.,
2002; Selbach et al., 2009), whereas the CM sequence binds
to PAR1 and c-Met receptor (Nesic et al., 2010; Saadat et al.,
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a22 and a23 serves as a regulatory sequence that alters struc-
tural and dynamic characteristics of C-terminal CagA by inter-
acting with CBS. Especially, the intramolecular NBS/CBS inter-
action influences turnover of the CagA-PAR1 complex formed
via the CM sequence (Figure 6D). Of note, the CM sequence is
localized immediately distal to CBS and thus the NBS/CBS inter-
action creates a lariat-like loop containing CM and EPIYA
sequences in the disordered C-terminal CagA. Because the
loop is fixed at both ends on the folded N-terminal CagA, the
loop formation makes the entire CagA structure more compact,
while C-terminal CagA becomes less mobile and less rotatable.
The conformational constraints may trigger disorder-to-order
transition observed in C-terminal CagA (Figure 6H), which under-
lies reduced turnover of the CagA-PAR1 complex that potenti-
ates CagA-SHP2 interaction and subsequent induction of the
hummingbird phenotype. The loop formation also fixes relative
positioning of C-terminal CagA to N-terminal CagA, which might
simplify tethering of two CagA proteins by a PAR1 dimer (Fig-
ure S5G) that could additionally promote CagA-SHP2 interaction
(Saadat et al., 2007; Hatakeyama, 2008). The NBS/CBS interac-
tion may therefore facilitate promiscuous interaction of CagA
with target proteins by inducing adaptive structures in the disor-
dered C-terminal CagA. This in turn indicates that N-terminal
CagA serves as a positive regulatory element of C-terminal
CagA by enhancing CagA membrane localization via the basic
patch and by strengthening the pathogenic scaffold/hub func-
tion of CagA through the NBS/CBS interaction. This idea is
also supported from the structural point of view that NBS is local-
ized to the opposite side of the basic patch in the folded
N-terminal CagA (Figure S5G).
Recent studies have also suggested additional roles of
N-terminal CagA in the function and regulation of CagA. Beside
its interaction with the above-described RUNX3 tumor sup-
pressor, the CagA N-terminal region associates with apoptosis-
stimulating protein of p53 (ASPP2) and thereby promotes p53
degradation (Buti et al., 2011). N-terminal CagA may therefore
contribute to gastric carcinogenesis by inhibiting tumor sup-
pressor proteins in host cells. Moreover, N-terminal CagA is
required for the delivery of CagA into host cells by the H. pylori
TFSS system (Hohlfeld et al., 2006) and is involved in the trans-
localization of CagA across the host cell plasma membrane by
interacting with integrin b1 (Jime´nez-Soto et al., 2009).
Elucidation of the tertiary structure of H. pylori CagA should
enable comprehensive understanding for the promiscuous/
versatile interaction of CagA with bacterial and host proteins in
a spatiotemporal manner. The present study also opens the
way to the development of a molecular targeting strategy that
effectively inhibits the oncogenic action of CagA.
EXPERIMENTAL PROCEDURES
Protein Expression, Purification, and Crystallization
Protocols used for DNA construction, protein expression in E. coli, protein
purification, and crystallization are outlined in the Supplemental Experimental
Procedures.
Limited Proteolysis
Recombinant CagA proteins were incubated with S. aureus V8 protease or
trypsin. The protein fragments produced by partial digestion were subjectedCto SDS-PAGE and subsequently silver-stained or electro-blotted onto a
PVDF membrane. After coomassie brilliant blue staining of the PVDF
membrane, the visualized protein bands were cut out and the N-terminal
sequences were determined by a peptide sequencer.
Circular Dichroism (CD) Spectropolarimetry
CD spectra of recombinant CagA proteins were measured in 12.5 mM Tris-
HCl, pH 7.0, 25 mM NaCl, 0.25 mM EDTA, and 0.25 mM DTT at 20C using
Jasco J-725 and J-820 spectropolarimeters.
1H-NMR Spectroscopy
1H-NMR spectra of recombinant CagA proteins were measured in 50mM Tris-
HCl, pH 7.0, 150 mMNaCl, 1 mM EDTA, and 1 mMDTT at 25C using a Varian
UNITY INOVA 500 spectrometer. 2,2-Dimethylsilapentane-5-sulphonic acid
was added to the protein sample and used as a reference standard.
Crystal Structure Determination
Diffraction data of CagA crystals were collected at PF-AR NE3A of PF in KEK
(Tsukuba, JAPAN) and 23-ID-D of the Advanced Photon Source (Argonne,
USA). The crystal structure of CagA(261–829) was determined by the MAD
method (Table 1) using the program autoSHARP (Vonrhein et al., 2007).
Densitymodification was performed using the programSOLOMON (Abrahams
and Leslie, 1996). The molecular model was constructed using the program
Coot (Emsley et al., 2010). Crystals of selenomethionine (SeMet)-introduced
CagA point mutants were utilized to help amino-acid assignment of the molec-
ular model (Table S1). The crystal structure of CagA(261-829) was refined
using programs Phenix.refine (Adams et al., 2010) and BUSTER (Global
Phasing Ltd., Cambridge, UK) (Table 1). The crystal structure of CagA(1-876)
was determined by the MR method using autoMR in Phenix (Adams et al.,
2010) and refined using programs Phenix.refine and BUSTER (Global Phasing
Ltd., Cambridge, UK) (Table 1). In the structures of CagA(261-829) and
CagA(1-876), no residues have fc angles in the disallowed and generously
allowed regions of their Ramachandran plots (Figure S3B). Details of the crys-
tallographic analysis are given in the Supplemental Experimental Procedures.
Phospholipid-Binding Assay
Phospholipid-binding assay on a membrane filter was performed using re-
combinant CagA proteins. Details of the assay are given in the Supplemental
Experimental Procedures.
Surface Plasmon Resonance Analysis
Surface plasmon resonance spectra were measured using Biacore X or
Biacore 3000 (GE Healthcare). Purified PAR1b(39-364) was immobilized on
a CM5 sensor chip (GE Healthcare) according to the manufacturer’s protocol.
Recombinant CagA proteins at indicated concentrations in HBS-EP solution
(GE Healthcare) were reacted with the immobilized PAR1b(39-364) at a flow
rate of 20 ml/min. Dissociation constants were calculated using Biaevaluation
software (GE Healthcare).
Static Light Scattering Analysis
Molecular weights (MWs) of recombinant CagA proteins were determined by
the static light scattering (LS) method in a buffer of 20 mM Tris-HCl, 500 mM
NaCl, pH 8.0. Sample solution was applied to the Superose 6 gel filtration
column and the eluted sample was introduced to miniDAWN Tristar (Wyatt
Technology) to measure the LS at 690 nm. The refractive index (RI) was also
measured with RID-10A (Shimadzu). The MW was estimated from the LS/RI
ratio.
Statistics
Statistics analysis was performed using either Student’s t test or Mann-
Whitney U test.
ACCESSION NUMBERS
Atomic coordinates and structure factors of CagA(1-876) and CagA(261-829)
have been deposited in the Protein Data Bank under accession codes 4DVY
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